Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Syndax Pharmaceuticals (SNDX) Return on Capital Employed (2016 - 2020)

Syndax Pharmaceuticals (SNDX) has 5 years of Return on Capital Employed data on record, last reported at 0.32% in Q4 2020.

  • For Q4 2020, Return on Capital Employed rose 79.0% year-over-year to 0.32%; the TTM value through Dec 2020 reached 0.32%, up 79.0%, while the annual FY2025 figure was 0.54%, 6.0% up from the prior year.
  • Return on Capital Employed reached 0.32% in Q4 2020 per SNDX's latest filing, up from 0.39% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.22% in Q2 2016 and bottomed at 1.12% in Q4 2019.
  • Average Return on Capital Employed over 5 years is 0.63%, with a median of 0.53% recorded in 2017.
  • Peak YoY movement for Return on Capital Employed: tumbled -49bps in 2018, then skyrocketed 79bps in 2020.
  • A 5-year view of Return on Capital Employed shows it stood at 0.42% in 2016, then decreased by -27bps to 0.54% in 2017, then crashed by -90bps to 1.02% in 2018, then dropped by -9bps to 1.12% in 2019, then skyrocketed by 71bps to 0.32% in 2020.
  • Per Business Quant database, its latest 3 readings for Return on Capital Employed were 0.32% in Q4 2020, 0.39% in Q3 2020, and 0.43% in Q2 2020.